Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 1
1985 2
1986 6
1987 4
1988 5
1989 8
1990 3
1991 5
1992 7
1993 9
1994 5
1995 3
1996 5
1997 5
1998 2
1999 3
2000 1
2001 1
2003 1
2005 2
2006 4
2007 2
2008 1
2009 8
2010 2
2011 6
2012 7
2013 9
2014 8
2015 6
2016 3
2017 3
2018 5
2019 6
2020 7
2021 7
2022 5
2023 5
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

162 results

Results by year

Filters applied: . Clear all
Page 1
Trial of Prasinezumab in Early-Stage Parkinson's Disease.
Pagano G, Taylor KI, Anzures-Cabrera J, Marchesi M, Simuni T, Marek K, Postuma RB, Pavese N, Stocchi F, Azulay JP, Mollenhauer B, López-Manzanares L, Russell DS, Boyd JT, Nicholas AP, Luquin MR, Hauser RA, Gasser T, Poewe W, Ricci B, Boulay A, Vogt A, Boess FG, Dukart J, D'Urso G, Finch R, Zanigni S, Monnet A, Pross N, Hahn A, Svoboda H, Britschgi M, Lipsmeier F, Volkova-Volkmar E, Lindemann M, Dziadek S, Holiga Š, Rukina D, Kustermann T, Kerchner GA, Fontoura P, Umbricht D, Doody R, Nikolcheva T, Bonni A; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. N Engl J Med. 2022 Aug 4;387(5):421-432. doi: 10.1056/NEJMoa2202867. N Engl J Med. 2022. PMID: 35921451 Clinical Trial.
[Presentation].
García-Ruiz PJ, Luquin MR, Martínez-Castrillo JC. García-Ruiz PJ, et al. Rev Neurol. 2012;55 Suppl 1:S1. Rev Neurol. 2012. PMID: 23169226 Spanish. No abstract available.
Impact of Safinamide on Patient-Reported Outcomes in Parkinson's Disease.
Espinoza-Vinces C, Villino-Rodríguez R, Atorrasagasti-Villar A, Martí-Andrés G, Luquin MR. Espinoza-Vinces C, et al. Patient Relat Outcome Meas. 2023 Oct 10;14:285-295. doi: 10.2147/PROM.S369590. eCollection 2023. Patient Relat Outcome Meas. 2023. PMID: 37840836 Free PMC article. Review.
Gangliosides and parkinsonism.
Herrero MT, Kastner A, Perez-Otaño I, Hirsch EC, Luquin MR, Javoy-Agid F, Del Río J, Obeso JA, Agid Y. Herrero MT, et al. Neurology. 1993 Oct;43(10):2132-4. doi: 10.1212/wnl.43.10.2132. Neurology. 1993. PMID: 8413979
Hydrogels for brain repair: application to Parkinson's disease.
Del Campo-Montoya R, Luquin MR, Puerta E, Garbayo E, Blanco-Prieto MJ. Del Campo-Montoya R, et al. Expert Opin Drug Deliv. 2022 Nov;19(11):1521-1537. doi: 10.1080/17425247.2022.2136161. Epub 2022 Nov 1. Expert Opin Drug Deliv. 2022. PMID: 36240170
Advanced Parkinson's disease: clinical characteristics and treatment. Part II.
Kulisevsky J, Luquin MR, Arbelo JM, Burguera JA, Carrillo F, Castro A, Chacón J, García-Ruiz PJ, Lezcano E, Mir P, Martinez-Castrillo JC, Martínez-Torres I, Puente V, Sesar A, Valldeoriola-Serra F, Yañez R. Kulisevsky J, et al. Neurologia. 2013 Nov-Dec;28(9):558-83. doi: 10.1016/j.nrl.2013.05.002. Epub 2013 Jul 21. Neurologia. 2013. PMID: 23880230 Free article. Review. English, Spanish.
[Neuropsychological profile of frontotemporal lobar degeneration].
Carmona-Abellán MM, Luquin MR, Lamet I, Pujol Giménez N, Esteve-Belloch P, Rivero M. Carmona-Abellán MM, et al. An Sist Sanit Navar. 2015 Jan-Apr;38(1):79-92. doi: 10.23938/ASSN.0056. An Sist Sanit Navar. 2015. PMID: 25963461 Free article. Review. Spanish.
162 results